Target Audience
This activity has been designed to meet the educational needs of Academic and Community Practitioners, from all oncology specialties, to include physicians, nurses and nurse practitioners, physician associates, pharmacist and other healthcare professionals treating all disease sites involved in the care of patients with cancer.
Educational
Objectives
After completing this activity, the participant should be better able to:
- Describe the rationale for mechanisms of action for molecular targeted and immunologic therapies used to treat cancer today;
- Summarize recent advances in targeted and immunologic treatment of hematologic malignancies and solid tumors;
- Identify patients who are appropriate candidates for targeted and immunologic therapies;
- Implement strategies from a healthcare team approach to reduce treatment-related toxicities, and optimize patient outcomes;
- Discuss promising targeted and immunologic approaches being tested in late-stage clinical trials